The ‘Prince of Wales Global Sustainability Fellowship Programme’ represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals.
In a new partnership with The University of Cambridge Institute for Sustainability Leadership (CISL) AstraZeneca was today announced as one of the founding members of the The Prince of Wales Global Sustainability Fellowship Programme. The programme aims to attract academics from around the world with the support of leading companies to identify breakthrough solutions to meet the UN Sustainable Development Goals (SDGs).
In a unique model for the University, up to 15 Prince of Wales Global Sustainability Fellows will be appointed to undertake three-year studies to mobilise global evidence on the world’s most pressing challenges with a view to enabling companies and policymakers to play a more catalytic role in building a sustainable economy.
AstraZeneca’s research scope will focus on SDG3: Good health and wellbeing. The research will explore topics around how world health systems can deliver higher standards of care to a growing population characterised by an older demographic and high expectations. The burden on health systems has increased as a result of diet and lifestyle choices and an overall rise in non-communicable disease in almost all parts of the world. In this context health systems rarely have the resources to invest in preventing ill health, focused as they are on dealing with acute healthcare priorities which feel impossible from an individual, social and political perspective to ignore.
This research forms part of AstraZeneca’s increasing effort to address non-communicable disease (NCD) prevention, including the established Young Health Programme and work to improve both human and environmental health through the Dunga Beach programme announced in May.
Other founding companies sponsoring the Fellowship Programme include: Sainsbury’s
Unilever, Anglian Water, Asda, The Equal Opportunities Foundation, Heathrow Airport Holdings, Paul and Michelle Gilding (individuals) and Sappi.
As a tribute to his 70th birthday year, and in recognition of his lifetime’s dedication to environmental issues, the Fellowship Programme is named in honour of CISL’s Patron The Prince of Wales.
This effort is even more urgent given the UN’s announcement last week that progress on the SDGs has been slow and not on track to reach its 2030 targets.
AstraZeneca’s sustainability strategy supports the SDGs through the three priority areas of Access to healthcare, Environmental protection and Ethics and transparency, underpinned by the sustainability Foundations, which include for example diversity and inclusion and human rights.
AstraZeneca is proud to be part of The Prince of Wales Global Sustainability Fellowship Programme, supporting research to positively impact SDG 3; Good health and wellbeing. By supporting a research Fellow to review the academic evidence for non-communicable disease prevention, we look forward to understanding and sharing more about the policies, practices and innovations necessary to deliver the economic and human benefits of sustainable health.
The Prince of Wales Global Sustainability Fellowship Programme will create a rich intellectual space for collaboration between researchers and industry as we seek breakthrough ideas and leadership actions to towards meeting the UN Sustainable Development Goals